Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Pratham EPC Projects Limited IPO opens on March 11, 2024 Business
  • ZARI JAIPUR Reveals the Highly Awaited UDHARAN- Themed Spring/Summer 2024 Collection Business
  • Resonite Scores All-India Rank without IIT Foundation a Remarkable Achievement Education
  • Premium Gujarati OTT platform ShemarooMe unveils trailer of yet another Gujarati web series‘Kshadyantra’. Business
  • Times Now honors the indomitable spirit of 12 ordinary Indians at the Amazing Indians Awards 2022 Lifestyle
  • Challenge, Inspire, Lead- Toastmasters District 98 ,Shaping Future Leaders Business
  • How pandemic propelled Digital Marketing Expert and Business Consultant Manish Singh to resurrect – WhalerWatt Digital Services Pvt. Ltd A
  • HOAC FOODS INDIA LIMITED Raises ₹1,000.00 Lakhs in Qualified Institutional Placement (QIP) Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Corium Introduces 2026 Italian Seating Trends to Indian Homes Business
  • Leo Lounger: Elevating Homes with Bespoke Luxury Furniture Packages Business
  • Digital Marketing Agency, The Wise Owl Helps Local Brands Become a Global Business Phenomenon Business
  • Inauguration of Electric Vehicles in TATA Steel Business
  • NAR India Partners with UCO to Revolutionize Indian Real Estate Through National MLS Initiative Business
  • Next Big Box Provides Leading Digital Marketing & Innovative IT Solutions for Business Growth Business

Recent Posts

  • Abhay Sinha Joins CineNow as Founding Member, Strategic Council
  • COMPUTEX 2026 Concludes Successfully as Global Innovation Shapes a New AI Ecosystem
  • Rajesh Nigam Explores the Healing Power of Gratitude and Positive Thinking in Heal Yourself with Mind Power & Gratitude
  • Sechin Discusses the Current State of Global Institutional Coordination
  • Smart Roads: How AI Traffic Enforcement Systems Are Changing the Urban Infrastructure

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Navasanjivani Madhavprash: to fight against the fear of heart attack Health
  • World Environment Day Celebrated at IDT: Inspiring the Next Generation through Earth Colors and Natural Dye Methods Press Release
  • AM/NS India Commences Land Acquisition To Set Up Integrated Steel Plant In Andhra Pradesh Business
  • Navitas Solar, one of the Leading Solar Module Manufacturer, has been named as the “Pride of Gujarat” Business
  • AGC Grants Scholarship – Get registered at AGC NEST-A Stimulant to the gateway of your Career Business
  • A2Z Medicals & Surgicals Bagged “Top 100 Franchise Brands of India & Brand of the Year 2022” Business
  • Anuj Wahi, The Brain behind KHC Healthcare’s 16+ Years of Sustainable Journey Business
  • BlinkX Introduces Advanced F and O Technical Scanners Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme